SERETIDE EVOHALER MDI 50/25

Seretide Evohaler is a prescription-only inhaler containing a combination of fluticasone propionate (50mcg) and salmeterol xinafoate (25mcg). This pressurized metered dose inhaler provides 120 doses and is CFC-free. It requires shaking well before each use.

Contraindications: Not for the relief of acute bronchospasm or sudden breathing problems. Caution: Use with caution in patients with cardiovascular disorders, hyperthyroidism, diabetes, or those on monoamine oxidase inhibitors (MAOIs). Pregnancy and Lactation: Consult your healthcare provider before use during pregnancy or breastfeeding. Drug Interactions: May interact with other medications; inform your healthcare provider of all medicines you are taking. Side Effects: Possible side effects include oral thrush, hoarseness, throat irritation, headache, and muscle cramps. Seek medical attention if you experience chest pain, rapid heartbeat, or worsening breathing problems.

Dual Action: Combines a corticosteroid and a long-acting beta-agonist for comprehensive asthma and COPD management. Convenient Dosing: Provides 120 doses, typically lasting 60 days with twice-daily use. Easy to Use: Metered-dose inhaler with a dose counter to track remaining doses. Trusted Brand: Manufactured by GSK Pharma, a reputable pharmaceutical company.

Brand: GSK Pharma Formulation: Metered-dose inhaler (MDI) Storage: Store below 25°C, protect from light, and do not freeze.

Active Ingredients: Fluticasone Propionate: 50 mcg per dose Salmeterol Xinafoate: 25 mcg per dose Excipients: Contains hydrofluoroalkane (HFA) as the propellant.